Cat.#: ACPP-1613
| Despition | RAB3IL1 Human Recombinant |
| SIZE | 2 µg |
| Purity | > 90.0% (SDS-PAGE) |
| Form | Sterile Filtered clear solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1675 | Human TOR1A Protein (AC1675) | 5 µg | inquiry |
| ACPP-1335 | Nicotinic Acetylcholine Receptor alpha 7 Blocking Peptide (AC1335) | 250 µg | inquiry |
| ACPP-1041 | Recombinant Human Wnt3a Protein (AC1041) | 50 µg | inquiry |
| ACPP-1065 | Recombinant Human Prostate Specific Antigen Protein (Fc Tag) (AC1065) | 50 µg | inquiry |
| ACPP-1284 | Nkx2.2 Blocking Peptide (AC1284) | 250 µg | inquiry |
| ACPP-1252 | Robo3 Blocking Peptide (AC1252) | 250 µg | inquiry |
| ACPP-1289 | Usherin Blocking Peptide (AC1289) | 250 µg | inquiry |
| ACPP-1605 | Human PNMT Protein (AC1605) | 5 µg | inquiry |
| ACPP-1093 | Synthetic Nanodisc Human CCR5 Protein (AC1093) | 10 µg | inquiry |
| ACPP-1832 | Human CRYZ Protein (AC1832) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.